A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

BACKGROUND: High-dose erythropoietin has been shown to have a neuroprotective effect in preclinical models of neonatal brain injury, and phase 2 trials have suggested possible efficacy; however, the benefits and safety of this therapy in extremely preterm infants have not been established. METHODS:...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:N Engl J Med
Päätekijät: Juul, S.E., Comstock, B.A., Wadhawan, R., Mayock, D.E., Courtney, S.E., Robinson, T., Ahmad, K.A., Bendel-Stenzel, E., Baserga, M., LaGamma, E.F., Downey, L.C., Rao, R., Fahim, N., Lampland, A., Frantz, I.D., Khan, J.Y., Weiss, M., Gilmore, M.M., Ohls, R.K., Srinivasan, N., Perez, J.E., McKay, V., Vu, P.T., Lowe, J., Kuban, K., O’Shea, T.M., Hartman, A.L., Heagerty, P.J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060076/
https://ncbi.nlm.nih.gov/pubmed/31940698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1907423
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia